Avidity determination: Utilization of a basic immunological mechanism allows improvement of the serodiagnosis of infections;Aviditatsbestimmung: Nutzung eines immunologischen grundvorganges fur eine verbesserte Infektionsserologie

Clinical Laboratory

Volumn 43, Issue 3, 1997, Pages 125-135

  Wolter, Tilmann ^a   Gassmann, Christoph ^a   Vetter, Veronika ^a   Bauer, Georg ^a,b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Affinity; Avidity; Immunity; Serology of infections

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

BINDING AFFINITY; DIAGNOSTIC VALUE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOLOGY; INFECTION; REVIEW; SERODIAGNOSIS;

EID: 0030773150     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (67)

1. Alpers C, Scheid C and Bauer G. Acute EBV infection results in IgM responses against unrelated viruses. Med Microbiol Letters 1994; 3: 306-14.
2. Andersson A, Vetter V, Kreutzer L and Bauer G. The avidities of IgG directed against viral capsid antigen (VCA) or early antigen (EA): useful markers for a more significant Epstein-Barr virus serology. J Med Virol 1994; 43: 238-44
3. Bauer G. IgM: ein variabler und mehrdeutiger diagnostischer Marker. Der Mikrobiologe 1996; 6: 44-51.
4. Bauer G. Die Aussagemöglichkeiten der Epstein-Barr-Virus-Diagnostik. Der Internist 1992; 33: 586-92
5. Bauer G. Epstein-Barr-Virus: Bedeutung und Moglichkeiten der Labordiagnostik. Therapeutische Umschau 1994; 51: 558-562
6. Bauer G. Rationale und rationelle EBV-Diagnostik. Clin Lab 1995; 41: 623-34
7. Bauer G. The rational basis for efficient EBV serology. Clin Lab 1995; 41: 623-34
8. Blackburn NK, Besselaar TG, Schoub BD, O'Connell KF. Differentiation of primary cytomegalovirus infection from reactivation using the urea denaturation test for measuring antibody avidity. J Med Virol 1991; 33: 6-9.
9. Boppana S B, Britt W J. Antiviral antibody responses and intrauterine transmission after primary maternal cytomegalovirus infection. J Infect Dis 1995; 171: 1115-21.
10. Brown SE, Zuckerman AJ, Howard CR, Steward MW. Affinity of antibody response in man to hepatitis B vaccine determined with synthetic peptides. Lancet 1984; 2: 184-187.
11. Chargeleque D, Stanley C M, O'Toole C M, Colvin B T and Steward M W. The affinity of IgG antibodies to gag p24 and p17 in HIV-1-infected patients correlates with disease progression. Clin Exp Immunol 1995; 99: 175-91.
12. Dahlquist GG, Ivarsson S, Lindberg B, Forsgren M. Maternal enteroviral infection during pregnancy as a risk factor for childhood IDDM. A population-based case-control study. Diabetes 1995; 44: 408-13.
13. De Ory F, Antonaya J, Fernandenz MV, Echevarria JM. Application of low-avidity immunoglobulin G studies to diagnosis of Epstein-Barr virus infectious mononucleosis. J Clin Microbiol 1993; 31: 1669-1671.
14. Devash Y, Calvelli T A, Wood D G, Reagan K J, Rubinstein A. Vertical transmission of human immunodeficiency virus is correlated with the absence of high-affinity/avidity maternal antibodies to the gp120 principal neutralizing domain. Proc Natl Acad Sci USA 1990; 87: 3445-49.
15. Eisen HN, Siskind GW. Variations in affinities of antibodies during the immune response. Biochemistry 1964; 3: 996-1008.
16. Enders G and Knotek F. Rubella total antibody avidity and IgG subclass-specific antibody avidity assay and their role in the differentiation between primary rubella and rubella reinfection. Infection 1989; 17: 218-26.
17. Foote J and Milstein C. Kinetic maturation of an immune response. Nature 1991; 352: 530-31.
18. Gassmann C and Bauer G. Avidity determination of IgG directed against tick-borne encephalitis virus improves detection of current infections. J Med Virol, in press (1997)
19. Gray J J. Avidity of EBV VCA-specific IgG antibodies: distinction between recent primary infection, past infection and reactivation. J Virol Meth 1995; 52: 95-104.
20. Gray J J, Cohen B J, and Desselberger U. Detection of human parvovirus B19-specific IgM and IgG antibodies using a recombinant viral VP1 antigen expressed in insect cells and estimation of time of infection by testing for antibody avidity. J Virol Meth 1993; 44: 11-24.
21. Gray JJ, Wreghitt TG. Immunoglobulin G avidity in Epstein-Barr virus infections in organ transplant recipients. Serodiagnosis and Immunotherapy in Infectious Disease 1989; 3: 389-393.
22. Guigno D, Coupland B, Smith E G, Farrel I D, Desselberger U and Caul E O. Primary humoral antibody response to Coxiella burnetii, the causative agent of Q fever. J Clin Microbiol 1992; 30: 1958-67.
23. Gut JP, Lablache C, Behr S and Kim A. Symptomatic mumps virus reinfections. J Med Virol 1995; 45: 17-23.
24. Hassan M M, Farghaly A M, Abdel-Fattah M M, and Seleem M A. Low avidity antibodies in diagnosis of recent experimental schistosomal infection. J Egypt Soc Parasitol 1994; 24: 193-98.
25. Hedman K and Rousseau SA. Measurement of avidity of specific IgG for verification of recent or primary rubella. J Med Virol 1989; 27: 288-92.
26. Hedman K and Seppälä I. Recent rubella virus infection indicated by a low avidity of specific IgG. J Clin Immunol 1988; 8: 214-221.
27. Hedman K, Hietala J, Tiilikainen A, Hartikainen-Sorri AL, Räihä K, Suni J, Väänänen P, and Pietilaïnen M. Maturation of immunoglobulin G avidity after rubella vaccination studied by an enzyme linked immunosorbent assay (avidity-ELISA) and by haemolysis typing. J Med Virol 1989; 27: 293-298.
28. Hedman K, Rousseau SA. Measurement of avidity of specific IgG for verification of recent primary rubella. J Med Virol 1989; 27: 288-292.
29. Hedman K, Vaheri A, Brummer-Korvenkontio M. Rapid diagnosis of hantavirus disease with an IgG-avidity assay. Lancet 1991; 338: 1353-56.
30. Holliman R E, Raymond R, Renton N, Johnson J D. The diagnosis of toxoplasmosis using IgG avidity. Epidem Infect 1994; 112: 399-408.
31. Junker A K and Tilley P. Varicella-zoster virus antibody avidity and subclass patterns in children with recurrent chickenpox. J Med Virol 1994; 43: 119-124.
32. Kallio-Kokko H, Vapalahti O, Hedman K, Brummer-Korvenkontio M, Vaheri A. Puumala virus antibody and immunoglobulin G avidity assays based on a recombinant nucleocapsid antigen. J Clin Microbiol 1993; 31: 677-680.
33. Karnoun PP. Denaturation of globular proteins by urea: breakdown of hydrogen or hydrophobic bonds? TIBS 1988; 13: 424-425.
34. Kangro HO, Manzoor S, Harper DR. Antibody avidity following varicella-zoster virus infections. J Med Virol 1991; 33: 100-105.
35. Lappalainen M, Koskiniemi M, Hiilesmaa V, Ammala P, Teramo K, Koskela P, Lebech M, Raivio K O, Hedman K. Outcome of children after maternal primary toxoplasma infection during pregnancy with emphasis on avidity of specific IgG. The study group. Ped Infect Dis Journal 1995; 14: 354-361.
36. Lehtonen OP, Meurman OH. An ELISA for the estimation of high-avidity and total specific IgG and IgM antibodies to rubella virus. J Virol Meth 1982; 5: 1-10.
37. Lehtonen OP, Meurman OH. Avidity of IgG antibodies against mumps, parainfluenza 2 and Newcastle disease viruses after mumps infection. J Virol Meth 1986; 14: 1-7.
38. Lindhout E, De Groot C. Follicular dendritic cells and apoptosis: life and death in the germinal centre. Histochemical Journal 1995; 27: 167-183.
39. Lutz E, Ward KN, and Gray JJ. Maturation of antibody avidity after primary human cytomegalovirus infection is delayed in immunosuppressed solid organ transplant patients. J Med Virol 1994; 44: 317-322.
40. Martin K A, Junker A K, Thomas E E, Van-Allen-M I, and Friedman J M. Occurrence of chickenpox during pregnancy in women seropositive for varicella-zoster virus. J Infect Dis 1994; 170: 991-995.
41. Mauracher CA, Mitchell LA, and Tingle AJ. Differential IgG avidity to rubella virus structural proteins. J Med Virol 1992; 36: 202-208.
42. Meurman O, Waris M and Hedman K. Immunoglobulin G antibody avidity in patients with respiratory syncytial virus infection. J Clin Microbiol 1992; 30: 1479-1484.
43. Morgan-Capner P, Thomas HIJ. Serological distinction between primary rubella and reinfection. Lancet 1988; 1:1397
44. Pincus SH, Shigeoka AO, Moe AA, Ewing L P, Hill HR. Protective efficacy of IgM monoclonal antibodies in experimental group B streptococcal infection is a function of antibody avidity. J Immunol 1988; 140: 2779-2785.
45. Polanec J, Seppala I, Rousseau S, and Hedman K. Evaluation of protein-denaturing immunoassays for avidity of immunoglobulin G to rubella virus. J Clin Lab Analysis 1994; 8: 16-21.
46. Rawal B. Potential role of IgG avidity for diagnosing toxoplasmosis. J Clin Pathol 1990; 43: 1032-1033.
47. Rousseau and Hedman K. Rubella infection and reinfection distinguished by avidity of IgG. Lancet 1988; 1: 1108-1109.
48. Schoub B D, Blackburn N K, Johnson S, McAnemey J M, and Miller B. Low antibody avidity in elderly chickenpox patients. J Med Virol 1992; 37: 113-115.
49. Simon F, Rahimy C, Krivine A, Levine M, Pepin JM, Lapierre D, Denamur E, Vernoux L, De Crepy A, Blot P et al., Antibody avidity measurement and immune complex dissociation for serological diagnosis of vertically acquired HIV-1 infection. J. Acquired Immune Def Synd 1993; 6: 201-207.
50. Söderlund M, Brown CS, Cohen BJ, and Hedman K. Accurate serodiagnosis of B19 parvovirus infections by measurement of IgG avidity. J Infect Dis 1995; 171: 710-713.
51. Söderlund M, Brown CS, Cohen BJ, Hedman K. Accurate serodiagnosis of öB19 parvovirus infections by measurement of IgG avidity. J Infect Dis 1995; 171: 710-713.
52. Steward MW and Lew AM. The importance of antibody affinity in the performance of immunoassays for antibody. J Immunol Meth 1985; 78: 173-190.
53. Thomas HIJ, Morgan-Capner P, Cradock-Watson JE, Enders G, Best JM, and O'Shea S. Slow maturation of IgG1 avidity and persistence of specific IgM in congenital rubella: implications for diagnosis and immunopathology. J Med Virol 1993; 41: 196-200.
54. Thomas HI, Morgan-Capner P. The avidity of specific IgM detected in primary rubella and reinfection. Epidem Infect 1990; 104: 489-497.
55. Thomas HI, Morgan-Capner P, Cradock-Watson J E, Enders G, Bewst JM, O'Shea S. Slow maturation of IgG1 avidity and persistence of specific IgM in congenital rubella: implications for diagnosis and immunopathology. J Med Virol 1993; 41: 196-200.
56. Thomas HI, Morgan-Capner P, Enders G, O'Shea S, Caldicott D and Best JM. Persistence of specific IgM and low avidity specific IgG1 following primary rubella. J Med Virol 1992; 39: 149-155.
57. Thomas HI, Morgan-Capner P. Rubella-specific IgG subclass avidity ELISA and its role in the differentiation between primary rubella and rubella reinfection. Epidemiol Infect 1988; 101: 591-598.
58. Thomas HI, Morgan-Capner P. Rubella-specific IgG1 avidity, a comparison of methods. J Virol Meth 1991; 31: 219-228.
59. Tuokko H. Detection of acute measles infections by indirect μ-capture enzyme immunoassays for immunoglobulin M antibodies and measles immunoglobulin G antibody avidity enzyme immunoassay. J Med Virol 1995; 45: 306-311.
60. Vetter V, Kreutzer L, Bauer G. Differentiation of primary from secondary anti-EBNA-1-negative cases by determination of avidity of VCA-IgG. Clin Diag Virol 1994; 2: 29-39
61. Ward KN, Dhaliwal W, Ashworth KL, Clutterbuck EJ, and Teo CG. Measurement of antibody avidity for hepatitis C virus distinguishes primary antibody responses from passively acquired antibody. J Med Virol 1994; 43: 367-372.
62. Ward KN, Gray JJ. Primary human herpesvirus-6 infection is frequently overlooked as a cause of febrile fits in young children. J Med Virol 1994; 42: 119-123.
63. Ward KN, Gray JJ, Fotheringham MW and Sheldon MJ. IgG antibodies to human herpesvirus-6 in young children: changes in avidity of antibody correlate with time after infection. J Med Virol 1993 a; 39: 131-138.
64. Ward KN, Gray JJ, Joslin ME, Sheldon MJ. Avidity of IgG antibodies to human herpesvirus-6 distinguishes primary from recurrent infection in organ transplant recipients and excludes cross-reactivity with other herpesviruses. J Med Virol 1993 b; 39: 44-49.
65. Werblin TP, Kim YT, Quagliata F, Siskind GW. Studies on the control of antibody synthesis. III. Changes in heterogeneity of antibody affinity during the course of the immune response. Immunology 1973; 24: 477-492.
66. Wreghitt TG, Gray JJ, Aloyisus S, Contreras M, Barbara JA. Antibody avidity test for recent infection with hepatitis C virus. Lancet 1990; 31: 335: 789
67. Wreghitt TG, Hicks J, Gray JJ, and O'Connor C (1986). Development of a competitive enzyme-linked immunosorbent assay for detecting cytomegalovirus antibody. J Med Virol 1986; 18: 119-129.